Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 24, 2018

DrugPatentWatch Database Preview

Novel Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for NOVEL LABS INC, and what generic and branded alternatives to NOVEL LABS INC drugs are available?

NOVEL LABS INC has fifty-six approved drugs.

There are two tentative approvals on NOVEL LABS INC drugs.

Summary for Novel Labs Inc

US Patents:	0
Tradenames:	44
Ingredients:	42
NDAs:	56

Drugs and US Patents for Novel Labs Inc

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novel Labs Inc	TEMAZEPAM	temazepam	CAPSULE;ORAL	071457-002	Jun 22, 2012	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Novel Labs Inc	PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL	bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride	FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL	202217-001	Aug 20, 2014		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Novel Labs Inc	MOXIFLOXACIN HYDROCHLORIDE	moxifloxacin hydrochloride	TABLET;ORAL	207285-001	Feb 13, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Novel Labs Inc	DICLOFENAC SODIUM	diclofenac sodium	SOLUTION;TOPICAL	205878-001	Dec 9, 2015	AT	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey

Cipla

Merck

Johnson and Johnson

Harvard Business School

Boehringer Ingelheim

US Department of Justice

Cerilliant

Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.